IAN F. SMITH - 02 Dec 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ David Tyronne Howton as attorney-in-fact for Ian F. Smith
Issuer symbol
SLDB
Transactions as of
02 Dec 2022
Transactions value $
$0
Form type
4
Filing time
05 Dec 2022, 17:02:44 UTC
Previous filing
04 Oct 2022
Next filing
15 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Award +13.2K +3.84% 356K 02 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person acquired 13,172 shares of the issuer's common stock pursuant to the issuer's acquisition of all of the outstanding capital stock of AavantiBio, Inc. on December 2, 2022.

Remarks:

Exhibit Index: 24.1 Power of Attorney